Liu et al. found that an intraperitoneal injection of SHP099 alleviated osteoarthritis progression, as SHP099 inhibited DOK1-mediated uridine phosphorylase 1 (UPP1) expression and subsequently upregulated the uridine level to maintain cartilage homeostasis [51]. The gene discussed is UPP1; the disease is osteoarthritis.